ExodusPoint Capital Management, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,060
-99.9%
423,898
+2.5%
0.02%
-34.8%
Q3 2022$1,745,000
+372.9%
413,612
+212.7%
0.02%
+360.0%
Q2 2022$369,000
-61.5%
132,253
-21.0%
0.01%
-58.3%
Q1 2022$958,000
+55.5%
167,502
+148.3%
0.01%
+100.0%
Q4 2021$616,000
+42.6%
67,463
+153.4%
0.01%0.0%
Q1 2021$432,000
-53.1%
26,627
-57.2%
0.01%
-66.7%
Q3 2020$922,000
-10.3%
62,210
-11.0%
0.02%
-33.3%
Q2 2020$1,028,00069,9060.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders